Press release
Surging Prevalence Of Chronic Kidney Diseases Sparks Growth In The Late-Stage CKD Drug Market
Late Stage Chronic Kidney Disease Drugs Market Size
What Is the Late Stage Chronic Kidney Disease Drugs Market Size and Projected Growth Rate?
The market size for drugs treating late stage chronic kidney disease has undergone rapid expansion in the past few years. It is projected to rise from $7.08 billion in 2024 to $7.92 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.9%. Factors contributing to the historic period's growth include enhanced diagnostic services, an aging society, increased incidences of diabetes and hypertension, increased awareness about kidney diseases, and the development and expansion of pharmaceutical research.
Over the coming years, the market for drugs targeted at late-stage chronic kidney disease is expected to experience significant growth. Forecasts indicate that it will increase to a value of $12.2 billion by 2029, boasting a compound annual growth rate (CAGR) of 11.4%. The known causes for this growth during the forecast period are increased spending on healthcare, the implementation of precision medicine tactics, a growing focus on regenerative medicine, an increased emphasis on care that prioritizes patients, and global campaigns to raise awareness of kidney disease. Key trends for this forecast period comprise the enhancement of regenerative medicine therapies, a surge in the use of telemedicine services for managing CKD, the creation of combined therapies, focus on early intervention methods, and a rising interest in diagnostics based on biomarkers.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12196
What Are the Major Segments in the Late Stage Chronic Kidney Disease Drugs Market?
The late stage chronic kidney disease drugs market covered in this report is segmented -
1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders
2) By Indication Type: Late Stage Chronic Kidney Disease Induced Hyperparathyroidism, Late Stage Chronic Kidney Disease Induced Hyperphosphatemia, Late Stage Chronic Kidney Disease Induced Hyperkalemia
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
Subsegments:
1) By Calcimimetics: Cinacalcet, Etelcalcetide
2) By Vitamin D: Calcitriol, Doxercalciferol, Paricalcitol
3) By Sterols: Ergocalciferol, Cholecalciferol
4) By Potassium Binders: Sodium Polystyrene Sulfonate, Patiromer, Sodium Zirconium Cyclosilicate
5) By Calcium-Based Phosphate Binders: Calcium Acetate, Calcium Carbonate
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12196&type=smp
What Are The Driving Late Stage Chronic Kidney Disease Drugs Market Evolution?
The escalating occurrence of chronic kidney diseases is anticipated to stimulate the expansion of the late-stage chronic kidney disease drug market. Chronic kidney diseases denote a variety of conditions impacting the functionality and form of the kidneys. Late-stage chronic kidney disease drugs are leveraged to manage blood pressure levels in patients and minimize protein loss, thereby retarding the progression of kidney deterioration, managing symptoms, and averting consequences. For instance, the Centers for Disease Control and Prevention (CDC), an American public health institution, reported in May 2024 that approximately 14% or a staggering 35.5 million adults in the U.S. are thought to be suffering from chronic kidney diseases. Hence, the high occurrence of chronic kidney disease is fuelling the expansion of the late-stage chronic kidney disease drug market.
Which Firms Dominate The Late Stage Chronic Kidney Disease Drugs Market Segments?
Major companies operating in the late stage chronic kidney disease drugs market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Kyowa Kirin Co Ltd., OPKO Health Inc., Evotec SE, Ionis Pharmaceuticals Inc., Akebia Therapeutics Inc., Ardelyx Inc., Concert Pharmaceuticals Inc., Pharmaxis Limited, Deltanoid Pharmaceuticals Inc., Liminal BioSciences Inc., Chinook Therapeutics Inc., Allena Pharmaceuticals Inc, Shield Therapeutics Plc
What Trends Are Expected to Dominate the Late Stage Chronic Kidney Disease Drugs Market in the Next 5 Years?
In the late-stage chronic kidney disease drug market, product innovation is emerging as a critical trend. Major market players are creating new drug products to maintain their market status. For instance, Bayer, a pharmaceutical and biotechnology company based in Germany, introduced Kerendia (finerenone) in India in February 2022. This first-of-its-kind non-steroidal, selective mineralocorticoid receptor antagonist is intended for patients suffering from type two diabetes and chronic renal disease. Finerenone operates by blocking the overactivation of the mineralocorticoid receptor (MR), considered to play a role in CKD development and cardiovascular harm.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report
Which Is The Largest Region In The Late Stage Chronic Kidney Disease Drugs Market?
North America was the largest region in the late-stage chronic kidney disease drugs market in 2024. The regions covered in the late-stage chronic kidney disease drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Late Stage Chronic Kidney Disease Drugs Market?
2. What is the CAGR expected in the Late Stage Chronic Kidney Disease Drugs Market?
3. What Are the Key Innovations Transforming the Late Stage Chronic Kidney Disease Drugs Industry?
4. Which Region Is Leading the Late Stage Chronic Kidney Disease Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surging Prevalence Of Chronic Kidney Diseases Sparks Growth In The Late-Stage CKD Drug Market here
News-ID: 3999423 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Late
How Factoring Services Help Businesses with Late Payments
US customers pay their invoices late in over 50% of cases, causing cash flow disruptions, missed opportunities, and financial strain. Factoring services can fix these issues for you in almost no time. This financial solution converts unpaid invoices into immediate working capital in 24 hours.
If late payments are a constant challenge for your business, learn how you can take advantage of factoring to tackle it.
1. Get a steady cash flow
More…
Late Night Revelry Awaits at The Winslow Lounge - NYC's Premier Late-Night Desti …
Image: https://www.getnews.info/wp-content/uploads/2024/06/1713864312.jpeg
New York, NY - The Winslow Lounge, located in the heart of the East Village, has quickly become the premier late-night destination [https://thewinslownyc.com/late-night-bar-nyc/] in New York City. With its vibrant atmosphere, exciting entertainment options, delicious food and drinks, and lively events, The Winslow offers an unforgettable nightlife experience.
"We wanted to create a place in NYC where people could truly let loose and have an amazing time," said Mark Tafoya,…
Desperate Puppy Seeks Rescue Before It’s Too Late!
FOR IMMEDIATE RELEASE
Tucson AZ, December 14th, 2021
The StarBarksCoffee.com rescue team was recently assaulted and threatened with being shot for assisting an abused, entangled puppy.
This Video of a neglected puppy desperately seeking rescue from a mentally unstable and violently aggressive owner was taken recently at an RV park in Texas during our annual "Journey Across America" in support of Animal Welfare.
We've contacted Texas authorities, but the Sheriff’s Department informed us the…
Transform your Traditional Businesses Before Its Too Late
Mob Inspire, an app development company has disrupted many industries by providing innovative software solutions to traditional businesses. We understand the rapidly changing tech environment and therefore equipt ourselves with those skills and tech tools which enable us to deal with challenging situations efficiently.
Mob Inspire takes the leverage of the latest tech trends like Blockchain, IoT and Cloud to deliver high-end products to its clients. The popularity…
Late-Night Treats for Late-Night Peeps
WHAT: La Motta’s, the neighborhood favorite in Boston’s SoWa District, is rolling out the late-night red carpet for its hospitality industry folks and friends, with Chef de Cuisine Justin Winter’s creative twists on after-hours snacks. Available every Sunday - Thursday from 10:00PM to last call, La Motta’s is the neighborhood joint for a late-night bash with flavorful bites and brews.
Launching Sunday, February 26th, 2017, guests can expect flavorful options…
Late payment – the hidden challenge facing Europe's businesses
A recent Europe-wide business survey has revealed no improvement in the pressure on European businesses from customers’ late payments, with 55 per cent of businesses across Europe reporting late payments resulting in loss of income, 63 per cent claiming additional pressures on liquidity, and 50 per cent citing late payments as having a direct impact on company growth.
In the Republic of Ireland, 47 per cent of businesses surveyed claimed…
